Prenatal Information Research Consortium
Description: prenatal molecular diagnostics conference Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated compa
prenatal (455) ngs (129) next-generation sequencing (56) biomarkers (43) molecular diagnostics (30) cell free dna (5) dna diagnostics (3) fetal cell (1) karotyping (1) cytogeneti (1)
Cell-free DNA screening and the potential for cell-based DNA testing continues to revolutionize the prenatal diagnostics field. While cell-free DNA tests are being used more and more in a clinical setting, with cell-based testing on its heels, there is still a pertinent need for improvements in sensitivity, specificity, and clinician and patient education in order to truly replace invasive testing. Alongside these developments, much research is being done in fetal whole exome sequencing and is beginning to
Program Advisors
Arthur Beaudet, MD, Chair, Department of Molecular & Human Genetics, Baylor College of Medicine
Prenatal Information Research Consortium